Study on clinical cases of atopic dermatitis in children

Abstract

Introduction. Allergic contact dermatitis (ACD) was once considered a rarity in children, but recent estimates suggest that it affects 4.4 million children in the United States alone. Currently, there is no cure, but an increasing number of innovative and targeted therapies show promise in gaining control over the disease, even in patients with refractory conditions. This has prompted us to investigate clinical cases of ACD. Aim of study. To evaluate clinical cases of atopic dermatitis in children. Methods and materials. An analysis was conducted on 43 medical records of pediatric atopic dermatitis cases over a 2-year period in outpatient practice. Results. Based on the SCORAD score, it was found that 7% of children exhibited a mild form of progression, 43% had a moderate form, and 50% showed severe progression. Many examined children also suffer from other associated allergic pathologies. Thus, out of the total number of allergic dermatitis patients, 24 children have bronchial asthma (9%) and allergic rhinitis (15%), aligning with existing literature. The most common manifestations observed in children were nonspecific dermatitis on the hands and feet (76%), dry skin (63%), itching (57%), facial erythema (44%), eczema (23%), etc. Current guidelines suggest that sedative antihistamines are favored over non-sedative antihistamines for alleviating allergic itching. We analyzed data from the National Ambulatory Medical Care Survey to compare antihistamine use between dermatologists and nondermatologists. Overall, dermatologists are more inclined to prescribe sedative antihistamines than non-sedative ones compared to non-dermatologists. Patients under the age of 21 were also more likely to receive sedative antihistamines than non-sedative ones. These findings highlight differential prescribing practices for atopic dermatitis among physicians. Conclusion. Providing appropriate antiallergic medication in conjunction with avoiding the detrimental effects of allergic factors will contribute to reducing the incidence of atopic dermatitis morbidity. Among first-generation antihistamines, the most commonly used are clemastine, chlorpheniramine, and cyproheptadine, which are preferably prescribed in acute forms of atopic dermatitis, while second and third-generation antihistamines are typically used in subacute and chronic forms. recent estimates suggest that it affects 4.4 million children in the United States alone. Currently, there is no cure, but an increasing number of innovative a nd targeted therapies show promise in gaining control over the disease, even in patients with re fractory conditions. This has prompted us to investigate clinical cases of ACD. Aim of study. To evaluate clinical cases of atopic dermatitis in childre n. Methods and materials. An analysis was conducted on 43 medical records of pediatric atopic dermatitis cases over a 2-year period in outpatient prac tice. Results. Based on the SCORAD score, it was found that 7% of children exhibited a mild form of progression, 43% had a moderate form, and 50% showed severe pr ogression. Many examined children also suffer from other associated allergic pathol ogies. Thus, out of the total number of allergic dermatitis patients, 24 children have bronchial a sthma (9%) and allergic rhinitis (15%), aligning with existing literature. The most common manifest ations observed in children were nonspecific dermatitis on the hands and feet (76%), dry skin (63%), itching (57%), facial erythema (44%), eczema (23%), etc. Current guidelines suggest that sedat ive antihistamines are favored over non-sedative antihistamines for alleviating allergic itching. We analyzed data from the National Ambulatory Medical Care Survey to compare antihistamine use between dermatologists and nondermatologists. Overall, dermatologists are more incline d to prescribe sedative antihistamines than non-sedative ones compared to non-dermatologists. Patien ts under the age of 21 were also more likely to receive sedative antihistamines than non-sedative ones. These findings highlight differential prescribing practices for atopic dermatitis am ong physicians. Conclusion. Providing appropriate antiallergic medication in conjunctio n with avoiding the detrimental effects of allergic factors will contribute to reducing the incidence of atopic dermatitis morbidity. Among first-generation antihistamines, the mos t commonly used are clemastine, chlorpheniramine, and cyproheptadine, which are preferably pr escribed in acute forms of atopic dermatitis, while second and third-generation antihistamines are typically used in subacute and chronic forms.